Molecular aspects of the inherited porphyrias

Journal of Internal Medicine

Volumn 247, Issue 2, 2000, Pages 169-178

  Sassa, S ^a   Kappas, Attallah ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Erythropoietic porphyria; Haem biosynthesis; Hepatic porphyria; Porphyria

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; COPROPORPHYRIN; COPROPORPHYRINOGEN OXIDASE; FERROCHELATASE; PORPHOBILINOGEN DEAMINASE; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; PROTOPORPHYRIN; PROTOPORPHYRINOGEN OXIDASE; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE; UROPORPHYRINOGEN III SYNTHASE;

ACUTE INTERMITTENT PORPHYRIA; CHEMICAL STRUCTURE; CLINICAL FEATURE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; ERYTHROPOIETIC PROTOPORPHYRIA; GENETIC HETEROGENEITY; HEME SYNTHESIS; HEPATIC PORPHYRIA; HUMAN; PATHOGENESIS; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

ERYTHROCYTES; HUMANS; MUTATION; PORPHOBILINOGEN SYNTHASE; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIA, ERYTHROPOIETIC; PORPHYRIA, HEPATOERYTHROPOIETIC; PORPHYRIAS; PORPHYRIAS, HEPATIC; PORPHYRINS;

EID: 0033981851     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00618.x     Document Type: Review

References (21)

1. 1 Kappas A, Sassa S, Calbraith RA et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1995; 2103-59.
2. 2 Erskine PT, Norton E, Cooper JB et al. X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolution. Biochemistry 1999; 38: 4266-76.
3. 3 Sassa S. ALAD porphyria. In: Berk PD, eds. Seminars in Liver Disease. New York: Thieme, 1998; 95-101.
4. 4 Chretien S, Dubart A, Beaupain D et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 1988; 85: 6-10.
5. 5 Puy H, Deybach JC, Lamoril J, Da Robreau AMS, Gouya VI. et al. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 1997; 60: 1373-83.
6. 6 Brownlie PD, Lambert R, Louie GV et al. The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria. Protein Sci 1994; 3: 1644-50.
7. 7 Lindberg RLP, Porcher C, Grandchamp B et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nature Genet 1996; 12: 195-99.
8. 8 Yoo HW, Warner CA, Chen CH, Desnick RJ. Hydroxy-methylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene. Genomics 1993; 15: 21-29.
9. 9 Desnick RJ, Glass IA, Xu W, Solis C, Astrin KH. Molecular genetics of congenital erythropoietic porphyria. Semin Liver Dis 1998; 18: 77-84.
10. 10 Mazurier F, Moreau-Gaudry F, Salesse S et al. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inh Metab Dis 1997; 20: 247-57.
11. 11 Delfau-Larue MH, Martasek P, Grandchamp B. Coproporphyrinogen oxidase: gene organization and description of a mutation leading to exon 6 skipping. Hum Mol Genet 1994; 3: 1325-30.
12. 12 Takahashi S, Taketani S, Akasaka J et al. Differential regulation of mouse coproporphyrinogen oxidase gene expression in erythroid and non-erythroid cells. Blood 1998; 92: 3436-44.
13. 13 Puy H, Robreau AM, Rosipal R, Nordmann Y, Deybach JC. Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in the human gene. Biochem Biophys Res Commun 1996; 226: 226-30.
14. 14 Meissner PN, Dailey TA, Hift RJ et al. A R 59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nature 1996; 13: 95-97.
15. 15 Rüfenacht U, Gouya L, Schneider-Yin X et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 1998; 62: 1341-52.
16. 16 Dailey HA, Finnegan MG, Johnson MK. Human ferrochelatase is an iron-sulfur protein. Biochemistry 1994; 33: 403-407.
17. 17 Ferreira GC, Franco R, Lloyd SG et al. Mammalian ferrochelatase, a new addition to the metalloenzyme family. J Biol Chem 1994; 269: 7062-65.
18. 18 Al-Karadaghi S, Hansson M, Nikonov S, Jonsson B, Hedersledt L. Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis. Structure 1997; 5: 1501-10.
19. 19 Wang X. Poh-Fitzpatrick M, Taketani S, Chen T, Piomelli S. Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria. Biochim Biophys Acta 1994; 1225: 187-90.
20. 20 Boulechfar S, Lamoril J, Montagutelli X et al. Ferrochelatase structural mutant (Fechm I Pas) in the house mouse. Genomics 1993; 16: 645-48.
21. 21 Tutois S, Montagutelli X, Da Silva V et al. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest 1991; 88: 1730-36.